Introduction
Benzidine (BZ) has been shown to induce tumors at various sites in laboratory animals (1, 2) . The major target organ in the rat and mouse is the liver, whereas tumors of the bladder are observed in dogs. BZ is also known to be responsible for the induction of bladder cancer in humans occupationally exposed to this compound (3, 4) . Morton et al. (5) have shown in vitro that BZ can be sequentially acetylated to N-acetylbenzidine (ABZ) and N,N'-diacetylbenzidine (DABZ). This latter species was then demonstrated to be a substrate for hepatic N,O-acyltransferase (5, 6) and hepatic sulfotransferase (7) and to form reactive intermediates that would covalently bind to nucleophiles. More recently, Morton and co-workers (8) reported that BZ and N-hydroxy-DABZ were more carcinogenic than DABZ in rats; however, the metabolic activation pathways responsible for tumor induction were not elucidated.
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short exposure period (9) . When this or other BZbased dyes are administered to animals, including man, BZ and its acetylated derivatives are detectable as urinary metabolites (10) (11) (12) (13) . Therefore, it has been suggested that the carcinogenicity of these compounds is likely to result from the action of the parent amine upon its release by microbial reduction of the dye in the alimentary tract. No data are yet available, however, to indicate the precise mechanism by which such compounds induce tumors. The work reported here and described in greater detail elsewhere (14) (14, 16) . Dried DNA samples were dissolved at 2 mg/mL in 5 mM Bis-Tris-HCl buffer, pH 7.1, which contained 5 mM MgCl2. Aliquots of this solution were used for colorimetric estimation of DNA (17) and for scintillation counting to determine total DNA binding. Samples were then enzymatically hydrolyzed and prepared for reversed-phase HPLC analysis by extraction of the adduct into nbutanol (14) . Only one peak of radioactivity was eluted from the column following injection of samples from either BZ-or ABZ-treated animals. Fractions associated with this peak were pooled and used to determine the pH-dependent solvent partitioning profile of the adduct (18) . After 4 hr, the DNA was isolated (19) , enzymatically hydrolyzed and prepared for HPLC analysis in the same manner as the in vivo samples. The major adduct peak was purified on a Waters CQ8-uBondapak Semiprep column by eluting with 45% methanol at a flow rate of 4 ml/min. The adduct was characterized by NMR and mass spectroscopy (14) . A pHdependent solvent partitioning profile was obtained and compared with that of the adduct formed in vivo from BZ or ABZ. The synthetic adduct was also coinjected with the radiolabeled in vivo adduct onto an analytical reversed-phase column. The column was eluted at 2 mL/min with 20% methanol in water for 10 min followed by a linear gradient over 10 min to 70% ethanol, and then increasing to 100% methanol over 5 min. UV absorbance was monitored at 282 nm and half-minute fractions were collected for scintillation counting.
Carboxylesterase Treatment of Adducts
The purified synthetic adduct (1 mg) obtained as described above was dissolved in 100,L DMSO and added to 10 mL 50 mM potassium phosphate buffer, pH 7.7. Carboxylesterase I and II (80 units each) were added and the mixture was incubated at 370C for 4 hr. The single product was purified on preparative HPLC and was characterized by NMR and mass spectral analysis. The product of reaction between N-acetoxy-DABZ and deoxyguanosine was treated similarly and the final product was characterized by mass and NMR spectral measurements.
Binding of DBU6 to Rat Liver DNA A total of 10 rats were treated with [ring-3H]DBU6. Half of the animals were injected IP at a dose of 12 mg/kg, and the remaining rats were treated at the same dose by gavage. One rat from each group was killed at 2, 8, 24, 48, and 168 hr after treatment. Livers were removed and DNA was extracted and purified as described above. Aliquots of washed liver (100 mg) were dissolved in 2 mL of Soluene (Packard Instrument Co., Illinois, USA) and counted for radioactivity to determine total uptake of dye. Purified DNA was estimated colorimetrically and associated radioactivity determined by scintillation counting. Samples at 24 and 168 hr were enzymically hydrolyzed and analyzed on HPLC as described for BZ-and ABZ-modified DNA.
Results
Covalent Binding of BZ, ABZ and DABZ to Rat Liver DNA [ When pH-dependent solvent partitioning experiments were performed on the purified DNA adduct from both BZ-or ABZ-treated animals, similar profiles were also observed (Fig. 2) . DNA at 370C and the single adduct that formed was isolated after enzymic hydrolysis and extraction into n-butanol. Purification by reversed-phase HPLC yielded a product which was characterized by NMR and mass spectroscopy as NAdeoxyguanosin-8-yl-N'-ABZ. The pH-dependent solvent partitioning profile (Fig. 2) and the chromatographic profile were identical to those obtained from the major in vivo adduct of either BZ or ABZ. This evidence, combined with pH stability and deacetylation data (14) , confirmed the identity of the in vivo adduct as being N-deoxyguanosin-8yl-N'-ABZ.
Synthesis of N(Deoxyguanosin-8-yl)NABZ and N(Deoxyguanosin-8-yl)BZ
The isomeric acetylated derivative N-(deoxyguan- (14) . The two acetylated and one deacetylated synthetic DNA adducts were coinjected onto an analytical reversed-phase HPLC column and all three compounds were well separated (Fig. 3) . The N-butanol-extractable fraction of hydrolyzed liver DNA from rats treated with either BZ or ABZ was coinjected with these three marker compounds and radioactivity was found associated only with N-deoxyguanosin-8-yl)N'-ABZ.
Binding of DBU6 to Rat Liver DNA bHepatic DNA was isolated and quantified by the diphenylamine reaction and the specific activity was determined by scintillation counting. cochromatography after incubation with base, acid, or carboxylesterase, and pH-dependent solvent partitioning, confirmed that the in vivo adduct and the synthetic marker were identical. The isomeric N-deoxyguanosin-8-yl)N-ABZ and the deacetylated adduct N-deoxyguanosin-8yl)BZ were also synthesized and were well separated from the in vivo adduct by HPLC. Therefore, as the deacetylated adduct was not detected in vivo, it may be assumed that Nhydroxy-BZ or N-hydroxy-N-ABZ are not proximate carcinogenic species in hepatocarcinogenesis in rats. Furthermore, diacetylated adducts were not found, which demonstrates that if N-hydroxy-DABZ was formed during metabolism, it does not act as a substrate for sulfotransferase enzymes. Thus, N-hydroxy-N'-ABZ, whether formed by sequential N-acetylation and N'-hydroxylation of BZ or by deacetylation of N-hydroxy-DABZ, appears a strong candidate proximate carcinogenic species of BZ and ABZ. NHydroxy-N'-ABZ may, of course, be further activated by O-esterification or by intermolecular N,0-acyltransfer (20) .
Direct Blue 6 is a polar dye derived from BZ by coupling it to two molecules of H-acid via diazo linkages. It has been suggested that the carcinogenicity of this and similar dyes results from reductive cleavage of the diazo bonds with consequent release of free BZ (10, (21) (22) (23) . Such reduction can occur as a result of action by gut microflora (22) or possibly by mammalian liver enzymes (24, 25) . Covalent binding of DBU6 to rat liver DNA occurred in animals dosed with [ring-3H]DBU6 either by gavage or by IP injection. Total binding following IP injection was greater than that observed in orally treated animals. Total binding was greatest in the 7-day animals which could be explained by the slow release of the dye from tissues to which it is bound by ionic interaction. In contrast to the ABZ adduct obtained from BZ and ABZ treatments, the major adduct which resulted from DBU6 administration coeluted with N-deoxyguanosin-8-yl)BZ. It would appear from these preliminary data that metabolism of the azo dye is not as simple as reduction to BZ before activation to form a reactive intermediate.
